News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smith Bryan E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/02/2023 |
4
| Smith Bryan E. (General Counsel, Corporate Sec) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 179,000 options to buy
@ $2.3, valued at
$411.7k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Smith Bryan E. (General Counsel, Corporate Sec) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 120,000 options to buy
@ $3.97, valued at
$476.4k
|
|
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 77,606 shares
@ $0 |
|
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 70,000 options to buy
@ $6.88, valued at
$481.6k
|
|
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|